e-learning
resources
Virtual 2020
Pre-Congress Content
Mechanistic insight into lung injury and repair
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
ECM-alginate microcarriers for alveolar regeneration in COPD
D. Bölükbas (Lund, Sweden), Z. Rahman (Enschede, Netherlands), S. Tas (Lund, Sweden), S. Lindstedt (Lund, Sweden), H. Gardeniers (Enschede, Netherlands), A. Susarrey Arce (Enschede, Netherlands), D. Wagner (Lund, Sweden)
Source:
Virtual Congress 2020 – Mechanistic insight into lung injury and repair
Session:
Mechanistic insight into lung injury and repair
Session type:
E-poster session
Number:
560
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Bölükbas (Lund, Sweden), Z. Rahman (Enschede, Netherlands), S. Tas (Lund, Sweden), S. Lindstedt (Lund, Sweden), H. Gardeniers (Enschede, Netherlands), A. Susarrey Arce (Enschede, Netherlands), D. Wagner (Lund, Sweden). ECM-alginate microcarriers for alveolar regeneration in COPD. 560
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Role of the TGFß1-mTOR axis in fibroblast-directed alveolar epithelial regeneration in IPF
Source: International Congress 2019 – Damage and remodelling in pulmonary fibrosis
Year: 2019
Alveolar epithelial wound repair is delayed by scenescent lung fibroblasts in IPF
Source: International Congress 2019 – Extracellular matrix formation and remodelling in physiology and disease
Year: 2019
Lineage differentiation of pulmonary alveolar fibroblasts
Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation
Year: 2012
Fibrocyte accumulation in the airway walls of COPD patients
Source: Eur Respir J, 54 (3) 1802173; 10.1183/13993003.02173-2018
Year: 2019
Epithelial stem cells at the intersection of tissue regeneration and pulmonary fibrosis
Source: Eur Respir Monogr 2021; 91: 290-305
Year: 2021
PP206 – Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids
Source: ERS Lung Science Conference 2021
Year: 2021
The regeneration of the lung alveolus
Source: International Congress 2018 – Pathophysiology of the human lung alveolus
Year: 2018
Remodelling in the bronchi of patients with COPD: defective ECM deposition and repair by pulmonary fibroblasts
Source: Annual Congress 2013 –Immunopathology of COPD: contribution of advancements of new therapeutic agents
Year: 2013
Airway and alveolar epithelial cells in culture
Source: Eur Respir J, 54 (5) 1900742; 10.1183/13993003.00742-2019
Year: 2019
No evidence of corticosteroid resistance in COPD alveolar macrophages
Source: Annual Congress 2009 - Translational research/biomarkers
Year: 2009
Progenitor cells for alveolar regeneration
Source: Research Seminar 2014 - The many faces of stem cells in respiratory diseases
Year: 2014
The role of altered stem cell function in airway and alveolar repair and remodelling in COPD
Source: Eur Respir Monogr 2021; 91: 322-339
Year: 2021
Remodelling of peripheral lung tissue in COPD
Source: Eur Respir J 2008; 31: 913-914
Year: 2008
Phenotype polarization of alveolar macrophages in COPD patients
Source: Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics
Year: 2010
Expansion of alveolar parenchymal and pulmonary vessel-associated lymphoid follicles in COPD
Source: Annual Congress 2009 - COPD: basic science and clinical studies
Year: 2009
Reduced haemeoxygenase-1 immunoreactivity in alveolar macrophages in severe COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 75s
Year: 2001
Small airway fibroblasts from COPD patients are senescent and pro-fibrotic
Source: International Congress 2018 – New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases
Year: 2018
LSC - 2021 - Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids
Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension
Year: 2021
Altered phenotype of COPD primary fibroblasts from airway and alveolar tissues: proliferation and apoptosis.
Source: International Congress 2019 – Research and innovation in airway diseases
Year: 2019
Alveolar stem cells in lung development and regrowth
Source: Eur Respir Monogr 2021; 91: 17-30
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept